Metre
Oakland, California, United States
Metre develops MetreAce, a scientifically proven, noninvasive breath acetone measurement device. It delivers metabolic health insights with the accuracy of a blood BHB ketone test at a fraction of the cost. The device pairs with an iOS app for a seamless user experience, enabling consumers to track their metabolic status easily. Utilizing field-tested volatile organic compound (VOC) breath testing technology backed by patent-protected intellectual property, MetreAce provides clinical-grade data. It allows users to understand how daily food and activity decisions impact their health through individualized, actionable feedback without the pain or expense of blood tests.
Company Info
- Founded
- 2019
- Website
- www.metre.ai/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Metre?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.